Darling Ingredients
DAR
60.02
-1.15
-1.88%
Darling Ingredients
US · DAR
#1472 by market cap
Listed 1970
60.02
-1.15
-1.88%
Live - 5344 symbols - heartbeat 33s ago
· 2026-10-08 08:34
Pre-market
60.05
+0.05%
After-hours
60.02
0.00%
- Market cap
- 9.47B
- P/E (TTM)i
- 16.13
- P/Bi
- 1.81
- EPSi
- 0.39
- Div yieldi
- 0.00%
- 52W posi
- 76%
Reader sentiment
Are you bullish or bearish on DAR?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
Company notice
Darling Ingredients: Darling Ingredients Inc. - Flex Position Consolidation Option Symbol: 1DAROCC · 2024/8/20
-
Company notice
VELOCITY: Notice of Person Ceasing (Section 139 of CA 2016) - SHENG DAR HOLDING SDN. BHD.Bursa Malaysia · 2025/1/2
-
Company notice
Dare Bioscience | 8-K: Daré Bioscience Reports First Quarter 2024 Financial Results and Provides Company Update Conference Call and Webcast Today at 4:30 p.m. ET Development Program Highlights and Anticipated 2024 MilestonesSEC · 2024/5/14
-
BofA Securities Maintains Darling Ingredients(DAR.US) With Buy Rating, Maintains Target Price $90Market Newswire · 2026/9/30
-
Rating change
Barclays Initiates Darling Ingredients(DAR.US) With Hold Rating, Announces Target Price $58Market Newswire · 2026/6/22
-
Rating change
TD Cowen Maintains Darling Ingredients(DAR.US) With Buy Rating, Cuts Target Price to $70Market Newswire · 2026/6/23
-
J.P. Morgan Maintains Darling Ingredients(DAR.US) With Buy Rating, Raises Target Price to $82Market Newswire · 2026/8/5
-
UBS Maintains Darling Ingredients(DAR.US) With Buy Rating, Raises Target Price to $88Market Newswire · 2026/9/22
-
Rating change
BofA Securities Maintains Darling Ingredients(DAR.US) With Buy Rating, Announces Target Price $90Market Newswire · 2026/7/31
-
Rating change
BMO Capital Maintains Darling Ingredients(DAR.US) With Buy Rating, Raises Target Price to $80Market Newswire · 2026/7/31
-
Rating change
Barclays Maintains Darling Ingredients(DAR.US) With Hold Rating, Raises Target Price to $65Market Newswire · 2026/8/4
-
Company notice
Dare Bioscience | 8-K: Daré Bioscience Reports Second Quarter 2024 Financial Results and Provides Company Update Conference Call and Webcast Today at 4:30 p.m. ETSEC · 2024/8/13
-
Rating change
TD Cowen Maintains Darling Ingredients(DAR.US) With Buy Rating, Raises Target Price to $80Market Newswire · 2026/7/27
-
Company notice
Dare Bioscience | 8-K: Daré Bioscience Reports Third Quarter 2024 Financial Results and Provides Company Update Conference Call and Webcast Today at 4:30 p.m. ET Development Program Highlights and Anticipated MilestonesSEC · 2024/11/15
-
Rating change
Baird Maintains Darling Ingredients(DAR.US) With Buy Rating, Raises Target Price to $86Market Newswire · 2026/7/31
-
UBS Maintains Darling Ingredients(DAR.US) With Buy Rating, Maintains Target Price $88Market Newswire · 2026/9/28
-
UBS Maintains Darling Ingredients(DAR.US) With Buy Rating, Maintains Target Price $78Market Newswire · 2026/7/1
-
Rating change
Barclays Maintains Darling Ingredients(DAR.US) With Hold Rating, Raises Target Price to $62Market Newswire · 2026/7/2
-
Rating change
BMO Capital Maintains Darling Ingredients(DAR.US) With Buy Rating, Maintains Target Price $74Market Newswire · 2026/5/12
-
Rating change
BofA Securities Maintains Darling Ingredients(DAR.US) With Buy RatingMarket Newswire · 2026/7/27
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-08 08:34:19 · For reference only, not investment advice and not tailored to your situation.